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Introduction
 Atrial fibrillation (AF) is the most frequently encountered 
arrhythmia in clinical practice, with an overall prevalence of 
0.4% in the general population.1) The prevalence of AF in-
creases with age, occurring in 3.8% of people age 60 years and 
older and in up to 9% of people over 80-year-of-age.2)3) As the 
proportion of the elderly in many societies continues to in-
crease, the number of patients with AF will likely increase. AF 
is associated with the significant clinical problems of systemic 
thromboembolism and hemodynamic deterioration. Quality 
of life and exercise capacity are also impaired in patients with 
AF. Data from the Framingham Heart Study suggest that the 
presence of AF is associated with a near doubling of both over-
all and cardiovascular mortality.4) Advances in imaging tech-
nology and in the understanding of the pathophysiology of AF 
are leading to more definitive and potentially curative thera-
peutic approaches. Among the various diagnostic tools, echo-
cardiography has an important role in the evaluation of cardi-
ac structure and function and risk stratification in AF. Two-
dimensional (2D) and Doppler study using transthoracic 
echocardiography (TTE) should be performed for the initial 
workup of all patients with AF, in order to acquire informa-
tion about left atrium (LA) and left ventricle (LV) size and 
function, and the presence of valvular, myocardial, pericardial 
and congenital heart disease which may predispose to AF. 
Echocardiography has also become an essential part of the 
guidelines for management of patients with AF,5) especially in 
elucidating the mechanisms of systemic thromboembolism in 
AF. Recently, the development of intracardiac echocardiogra-
phy (ICE) has allowed the real-time guidance of percutaneous 
interventions, including radiofrequency catheter ablation 
(RFCA) of foci in the pulmonary veins (PV) and left atrial ap-
pendage (LAA) closure procedures for patients with AF. In 
this article, we review the role of echocardiography in the 
evaluation and management of patients with AF.
Evaluation of LA Size and Function in AF
Anatomical assessment of LA
TTE is a reliable method to assess the anatomy of the LA. 
The measurement of LA anteroposterior diameter from M-
mode echocardiography in the parasternal long-axis or short-
axis window is commonly utilized in clinical work. This con-
ventional method has a tendency to underestimate true LA 
pISSN 1975-4612/ eISSN 2005-9655 
Copyright © 2011 Korean Society of Echocardiography 
www.kse-jcu.org DOI: 10.4250/jcu.2011.19.2.51
REVIEW J Cardiovasc Ultrasound  2011;19(2):51-61
Role of Echocardiography  
in Atrial Fibrillation
Tae-Seok Kim, MD and Ho-Joong Youn, MD, PhD
Division of Cardiology, Department of Internal Medicine, College of Medicine,  
The Catholic University of Korea, Seoul, Korea
Atrial fibrillation (AF) is most common arrhythmia and its prevalence appears to be increasing as the population ages. Echocar-
diography can play a key role in risk stratification and management of patients with AF. Transthoracic echocardiography allows 
rapid and comprehensive assessment of cardiac anatomical structure and function. Pulmonary vein flow monitoring using echo-
cardiography has the potential to an increasing role in the evaluation of cardiac function and AF ablation procedures. Transesoph-
ageal echocardiography also provides accurate information about the presence of a thrombus in the atria and thromboembolic 
risk. The novel technique of intracardiac echocardiography has emerged as a popular and useful tool in the everyday practice of 
interventional electrophysiology. Other imaging modalities, such as computed tomography and magnetic resonance imaging 
have complementary roles in risk stratification and assessment of patients with AF. Echocardiography continues to be the founda-
tion of clinical evaluation and management of AF.
KEY WORDS: Atrial fibrillation · Transthoracic echocardiography · Transesophageal echocardiography.
•	Received: March 21, 2011  •	Revised: May 7, 2011  •	Accepted: May 25, 2011   
•	Address for Correspondence: Ho-Joong Youn, Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The  
  Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul 137-701, Korea     Tel: +82-2-2258-1101, Fax: +82-2-2258-1103, E-mail: younhj@catholic.ac.kr
•	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  
  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Cardiovascular Ultrasound 19 | June  2011
52
size, because the shape of the LA is not spherical and enlarge-
ment of the LA is often asymmetrical.6) Hence, 2D derived 
LA volume assessment using the biplane area-length method 
or the Simpson’s method provides more accurate measures of 
LA size.7) A horizontal line needs to be drawn across the mi-
tral annular plane, and the LA area does not include the funnel 
of the mitral valve leaflets (Fig. 1). When tracing the outline 
of the LA, the LAA and the confluence of the PVs are exclud-
ed from the measurement. The reference value for 2D echocar-
diographic maximum LA volume indexes is 22 ± 6 mL/m2.7)8) 
A LA volume index of 29 mL/m2 is usually considered the up-
per limits of the normal value.7) More recently, three-dimen-
sional (3D) echocardiography for assessing LA volume has 
been available and has demonstrated good correlation with bi-
plane 2D measurements.9) However, studies on 3D echocar-
diographic measurement of LA volume have been too small, 
and there is no consensus on the methods or comparisons with 
established normal values. LA size has been established as a 
prognostic marker for both adverse cardiovascular events as 
well as overall outcomes.10-12) According to the data from the 
Framingham study, a 5-mm increase in LA dimension was as-
sociated with a 39% increased risk for subsequent develop-
ment of AF.4) Psaty et al.13) demonstrated that subjects in sinus 
rhythm with a LA dimension over 5.0 cm had about four 
times the risk of developing AF during the following period 
of surveillance. Increased LA volume, likewise LA dimension, 
is predictive of subsequent AF11) and it has been confirmed 
that LA volume is a superior measure over LA dimension for 
predicting outcomes of AF.14) LA enlargement is associated 
with a low probability of successful cardioversion for chronic 
AF or maintenance of sinus rhythm.15)16) An increased LA vol-
ume index can predict recurrence of AF after RFCA.17) Al-
though AF promotes further LA enlargement, cardioversion 
and maintenance of sinus rhythm may reverse this process. 
Van Gelder et al.18) reported that after restoration and long-
term maintenance of sinus rhythm, echocardiographic atrial 
dimensions may decrease. Reant et al.19) also demonstrated 
that RFCA for isolated AF reverse morphological remodeling 
of the LA after restoration of sinus rhythm.
Functional assessment of LA
In addition to providing information about atrial anatomy, 
echocardiography is also a potent tool for assessment of atrial 
function. With the loss of atrial booster pump function in AF, 
the LA-LV pressure gradient during early LV filling is in-
creased by elevation of the LA pressure to maintain stroke vol-
ume.20) Thus, a reduction in both LA compliance and volume 
has been observed with the onset of AF that further decreases 
cardiac function and increases the risk of thromboembolism. 
The change of the LA function in different phases can be eval-
uated non-invasively by echocardiography, utilizing not only 
usual methods including transmitral flow and changes in LA 
area and volume, but also novel techniques such as tissue 
Doppler imaging (TDI) and strain imaging.
Transmitral inflow patterns by pulsed wave Doppler pro-
vides information of LA mechanical function. The peak trans-
mitral inflow velocity of the late diastolic filling wave (A) is 
commonly used as a measure of LA mechanical function,21) 
but it cannot be measured in AF because of the absence of the 
atrial waveform. The peak A wave velocity has been used in 
the serial follow-up of LA function in patients with AF after 
cardioversion22) and RFCA.23) The time-velocity integral of 
the A wave and the atrial fraction (i.e., the ratio of the time-
velocity integral of the mitral A wave to that of the total dia-
stolic transmitral flow) may be used as a parameter of LA 
function.24) 
TDI allows the quantification of the low-velocity, high-am-
plitude, long-axis intrinsic myocardial velocities in both systo-
le and diastole, and provides a relatively load-independent 
measure of both LV systolic and diastolic function.25) The peak 
velocity at the mitral annulus in late diastole, following atrial 
contraction (A’ or Aa velocity) can be utilized as a rapid and ac-
curate marker of atrial function.26) The A’ velocity correlates 
with other parameters of atrial function such as peak A velocity 
Fig. 1. Biplane left atrial (LA) volume measurement in apical 4 chamber (A) and apical 2-chamber (B) views of transthoracic echocardiography. LV: left 
ventricle, LAA: left atrial appendage.
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of mitral inflow, atrial fraction and atrial ejection force.26) An-
other study also demonstrated that the tissue Doppler A’ veloc-
ity correlates with LA fractional area and volume change.27) 
Doppler strain and strain rate imaging are derivatives of tis-
sue Doppler velocities. TDI quantifies global tissue motion ve-
locity whereas strain and strain rate represent the extent of local 
tissue deformation and its rate, respectively (Fig. 2). Strain 
measures the myocardial deformation during a cardiac cycle, 
and strain rate measures the tissue velocity gradient within 
the myocardium. Strain and strain rate imaging may over-
come the major limitation of TDI, and may be largely inde-
pendent of translational effects due to tethering by neighbor-
ing myocardial segments.
Using TDI and/or strain imaging techniques, it was found 
the decreased compliance of LA walls, the impairment of the 
reservoir and conduit function of LA, and the loss of the 
booster pump function in patients with AF.28)29) With the de-
gree of LA enlargement, LA mechanical dysfunction has 
emerged as an independent predictors for the maintenance of 
sinus rhythm after successful cardioversion29) and RFCA.30) 
Atrial stunning is characterized by reduced atrial mechani-
cal function after restoration of sinus rhythm from AF, which 
may last several weeks and which is associated with increased 
risk of thromboembolism. This phenomenon is well recog-
nized with peak A velocity of transmitral inflow22)24) as well as 
TDI or strain imaging.31) This suggests that a dissociation of 
electrical and mechanical recovery occurs after successful resto-
ration of sinus rhythm, with a delay in gradual improvement 
of atrial mechanical function.
These parameters, mentioned above, can only be easily mea-
sured in sinus rhythm and are often not applied to the state of 
AF. Other LA functional parameters, which are rhythm inde-
pendent, have been recently suggested as being required.32) 
More studies and trials to be accepted and validate these pa-
rameters are needed to use routinely in clinical practice.
Assessment of LV Diastolic Function  
in AF
The presence and severity of diastolic dysfunction are associ-
ated with an increased risk for AF and heart failure in patients 
with sinus rhythm. Furthermore, the risk for heart failure is 
markedly increased once AF develops.33) The evaluation of dia-
stolic function in patients with AF has remained a clinical 
challenge, because the impairment of the LA mechanical func-
tion and the variable cycle lengths make the evaluation of dia-
stolic function difficult. Several new methods have been intro-
Fig. 2. Representative left atrial (LA) myocardial velocity using tissue Doppler image (TDI), strain rate (SR), and strain curves in a normal subject (A, B, 
and C, respectively) and a patient with atrial fibrillation (AF) (D, E, and F, respectively). The sample volume is placed at the mid-level of inter-atrial 
septum. In the patients with AF, no decrease in SR by atrial contraction was observed, but small phasic movements by the AF wave were recorded. 
Using TDI-derived velocity and SR parameters, it was found that the LA mechanical function was significantly decreased in AF as reflected by 
reduction in the S’ and/or E’ wave in the absence of the A’ wave during late diastole. S’ wave: ventricular systolic wave, E’ wave: ventricular early 
diastolic wave, A’ wave: late diastolic wave (atrial contraction).
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duced to be useful in measuring diastolic dysfunction of patients 
with AF. All echocardiographic parameters, which are ob-
tained in the context of AF, should be measured and averaged 
from 5 to 10 cardiac cycles.
Early transmitral flow deceleration time (DT) provides rela-
tively accurate assessment of LV diastolic function in the setting 
of AF.34)35) Matsukida et al.36) demonstrated that a cutoff value of 
mitral DT ≤ 100 ms predicted a mean of pulmonary capillary 
wedge pressure (PCWP) ≥ 18 mmHg with sensitivity of 80% 
and specificity 85%. In AF, mitral flow measurements usually 
include peak LV early diastolic filling velocity (E) and DT over 
5 to 10 cardiac cycles. A cycle length equivalent to a heart rate 
of 60 to 80 beats/min, with the interval ≥ 70 ms between the 
end of transmitral inflow and the onset of the QRS complex, is 
preferred (Fig. 3).34) 
Peak E velocity is dependent on LV relaxation and LA pres-
sure.34) To correct for LV relaxation, peak E velocity can be 
used as a ratio to the tissue Doppler early diastolic mitral an-
nular motion velocity (e’) (Fig. 4). TDI assessment of e’ veloci-
ty is relatively independent of LA pressure.37) E/e’ (septal) > 15 
and E/e’ (lateral) > 10 have been shown to be highly specific 
for elevated LV filling pressure.38)39) The E/e’ has been validat-
ed for LV diastolic filling pressure.40)
Color M-mode Doppler assessment of mitral inflow propa-
gation velocity (Vp) provides visualization of the temporal and 
spatial propagation flow along a single scan line from the an-
nulus area to the LA apex throughout the diastolic period. A 
Vp < 45 cm/s is consistent with the presence of diastolic dys-
function (Fig. 5).41)
The isovolumic relaxation time (IVRT) is the time from the 
aortic valve closure to the onset of mitral inflow and has been 
shown to be a strong negative correlation with mean PCWP 
in AF.34)35) Increased IVRT is a marker of impaired LV relax-
ation and a shortened IVRT reflects the increased LV chamber 
stiffness.42)
There may be advantages to the use of regional strain rate 
imaging for assessment of diastolic function in patients with 
AF. In AF, there could be regional differences in diastolic fill-
ing depending on the LV response to the fibrillating atria. 
Therefore, regional strain rate imaging is expected to be a 
promising technique for assessing diastolic dysfunction in AF. 
However, more studies will be needed before its application to 
the clinical practice in patients with AF.
Pulmonary Venous Flow Assessment  
in AF
Pulmonary venous blood flow (PVF) exhibits a pulsatile be-
havior, which is related to LA pressure and function, mitral 
valve function, and LV compliance. Echocardiography helps to 
define characteristic flow patterns in AF. The disappearance of 
atrial reverse flow, a decrease in systolic flow with a greater di-
astolic than systolic flow, a prolonged onset of systolic flow and 
the appearance of an early systolic reverse flow are characteris-
Fig. 3. Pulsed wave Doppler study of transmitral inflow in atrial 
fibrillation. Arrow indicates early transmitral flow deceleration time (DT). 
E represents peak LV early diastolic filling velocity. Peak E velocity and 
DT vary depending on cardiac cycle length. LV: left ventricle.
Fig. 4. Tissue Doppler imaging of the septal mitral annular velocities (e’) 
in a patient with atrial fibrillation. The measurements should be averaged 
over 5 to 10 cardiac cycles.
Fig. 5. Color M-mode, to calculate mitral inflow propagation velocity, is 
acquired from the apical 4-chamber view by placing a cursor over the 
center of mitral inflow and reducing the Nyquist limit for flow toward 
apex to a point when the central color turns blue.Role of Echocardiography in Atrial Fibrillation | Tae-Seok Kim and Ho-Joong Youn
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tic findings in AF. The disappearance of atrial reverse flow can 
be explained by the loss of active LA contraction. A decrease 
in systolic PVF has been also found to correspond closely to 
LAA dysfunction and spontaneous echo contrast (SEC) forma-
tion.43) The change of PVF in AF seems to reflect a alteration in 
LA function, mainly atrial compliance, and reservoir function.
PVF pattern can be used as a monitoring tool for recovery of 
LA mechanical function after restoration of sinus rhythm with 
cardioversion or RFCA. Low systolic PVF obtained during AF 
(before cardioversion)44) as well as obtained during sinus rhythm 
(immediately after cardioversion)45) was associated with AF re-
currence at 6 and 12 months after electrical cardioversion, re-
spectively. In contrast, an early systolic PVF peak velocity > 57 
cm/s predicted good mechanical function recovery with 96% 
specificity indicating that preserved reservoir function of LA 
during AF is predictive of satisfactory recovery of mechanical 
function after PV isolation.46) 
Pulmonary venous diastolic DT is very useful to predict dia-
stolic LV filling pressure, as estimated by PCWP in AF.47) Pul-
monary venous DT is calculated as the time between peak dia-
stolic velocity and the upper deceleration slope extrapolated to 
the zero baseline (Fig. 6). Measurements are usually done in 5 
to 10 cardiac cycles, with a cycle length equivalent to heart rate 
of 60 to 80 beats/min. Pulmonary venous DT correlated better 
with PCWP than transmitral DT in patients with AF.47) Mat-
sukida et al.36) demonstrated that pulmonary venous DT ≤ 150 
ms predicted PCWP ≥ 18 mm Hg with 100% sensitivity and 
96% specificity in patients with AF. 
A usage of monitoring PVF is the detection of PV stenosis 
after RFCA for AF, which occurs in 1% to 3% of current series. 
The PVF measurements using transesophageal echocardiogra-
phy (TEE) Doppler have allowed the detection of a significant 
PV stenosis following RFCA if the diagnosis is confined to a 
combination of elevated peak PV velocity (≥ 110 cm/s) with 
turbulence and little flow variation (Fig. 7).48) In one study, 
TTE was also available for diagnosing PV stenosis before and 
after RFCA for AF.49) However, it is currently accepted that 
TTE or TEE are limited by its inability to image deeply into 
all four PVs and are less useful in establishing the extent and 
location of PV stenosis.50) 
Role of Transesophageal 
Echocardiography in AF
Identification and risk stratification  
of LA/LAA thrombus
The risk of systemic emboli, probably arising in the LA cavi-
ty or LAA as a result of circulatory stasis, is an important con-
sideration in AF. AF is considered to be responsible for almost 
half of all cardiogenic thromboembolism. One of the primary 
goals of management of patients with AF is the prevention of 
thromboembolic events. TTE has a low sensitivity for detection 
of thrombi in LA and especially LAA.51) TEE provides excellent 
visualization of posterior cardiac structures and is the modality 
of choice for detecting LA or LAA thrombi with a sensitivity 
and specificity of approximately 95% to 100% (Fig. 8).52) 
Fig. 6. Pulmonary venous flow pattern demonstrated by transthoracic 
echocardiography in atrial fibrillation. Arrow indicates pulmonary venous 
diastolic deceleration time. S: peak systolic velocity, D: peak diastolic 
velocity.
Fig. 7. Transesophageal echocardiography can identify significant pul-
monary vein (PV) stenosis. Pulsed-wave Doppler of PV inflow > 110 cm/s 
confirms hemodynamically significant stenosis. LA: left atrium, AO: 
aorta, LSPV: left superior pulmonary vein.
Fig. 8. Image of thrombus (arrow) within the left atrial appendage 
discovered on a transesophageal echocardiography. LA: left atrium, 
AO: aorta.Journal of Cardiovascular Ultrasound 19 | June  2011
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Thrombus identification is also challenging even if the append-
age is visualized adequately. It is difficult to distinguish small 
thrombi from artifacts, including prominent trabecular struc-
tures, duplication artifacts, and adipose tissue within the trans-
verse sinus. It is necessary to attempt to differentiate any suspi-
cious abnormalities from thrombus in multiple views. 
In the absence of formed thrombi, a dense SEC has been 
demonstrated to be a strong predictor of ischemic strokes (Fig. 
9). When blood flow velocities are reduced in cardiac cham-
bers and especially in the LAA, “smoke-like” echoes swirling 
in the cavity may be seen. An annual thromboembolic event 
rate of 12% has been observed in patients with SEC compared 
to 3% in patients without it.53) The finding of thrombus on 
TEE represents a poor outcome. In one study, it was associated 
with an embolic risk up to 10.4% per year and a death risk of 
15.8% in a series of patients, most of whom were receiving 
anticoagulation therapy.54) 
LAA was sometimes regarded as just a minor extension of 
the atrium. However, the importance of its function has been 
brought up because of its contribution to formation of throm-
bus. The mechanical function of LAA is best assessed with 
TEE utilizing pulsed wave Doppler measurement of LAA 
emptying and filling velocities (Fig. 10). In patients with si-
nus rhythm, LAA contracts once per cardiac cycle, and flow 
velocities at the ostium demonstrate a biphasic pattern with 
peak velocities generally exceeding 50 cm/s.55) Low LAA emp-
tying flow velocities (< 20 cm/s) in AF correlate strongly with 
the presence of SEC and thrombus formation,56) whereas LAA 
emptying flow velocities > 40 cm/s predict greater likelihood 
to remain in sinus rhythm 1 year after successful cardiover-
sion.53) For patients with AF, TEE risk factors of clinical 
thromboembolism include LAA thrombus, severe SEC, de-
creased (< 20 cm/s) flow velocities at LAA ostium, and com-
plex aortic plaque (Table 1).56)57) A TEE performed 3 to 6 
months after AF ablation can also evaluate thromboembolic 
risk and need for long-term anticoagulation, as echocardio-
graphic risk factors may be present even if restoration of sinus 
rhythm is successful.
In addition to LAA Doppler assessment, measuring LAA 
area and ejection fraction, TDI, and 3D TEE are emerging as 
the new complementary techniques.58-60) These are performed 
rarely, however, and lack of data suggesting additional prog-
nostic value beyond simple flow velocity assessment.
TEE-guided early cardioversion
One of the primary goals of therapy in AF is the restoration 
and maintenance of sinus rhythm, with the aim of reducing 
symptoms and thromboembolic events. Cardioversion of AF 
to sinus rhythm can be performed with high rates of immedi-
ate success but unfortunately it may be complicated by em-
bolic events in up to 7% of patients if the procedure is not 
preceded by several weeks of anticoagulation.61)62) Convention-
al care of patients with AF of prolonged (more than 48 hours) 
of unknown duration had required that these patients should 
be treated with oral anticoagulation for at least 7 weeks (3 
weeks before and 4 weeks after cardioversion).63) The conven-
tional approach to antithrombotic management before trying 
cardioversion has several potential disadvantages. This has 
promoted the recent suggestion of alternative approaches, 
such as TEE-guided early cardioversion. The advantages of 
TEE-guided early cardioversion with short term anticoagula-
tion over the conventional strategy include the following: 1) 
In patients with no thrombus identified by TEE, the total du-
ration of anticoagulation can be reduced by weeks, potentially 
Fig. 9. Spontaneous echo contrast (*) swirling detected by transeso-
phageal echocardiography in a patient with atrial fibrillation. LA: left 
atrium, RA: right atrium.
Fig. 10. Pulsed wave Doppler of the left atrial appendage with 
transesophageal echocardiography. This picture demonstrates the 
decreased emptying and filling velocities in patients with atrial 
fibrillation.
Table 1. Clinical and echocardiographic predictors of systemic 
thromboembolism
Recent history of  systemic thromboembolism
Increased atrial size
Left atrial appendage thrombus or sludge
Severe spontaneous echo contrast
Left atrial appendage emptying velocity < 20 cm/s
Left ventricular systolic dysfunction
Complex aortic atheromaRole of Echocardiography in Atrial Fibrillation | Tae-Seok Kim and Ho-Joong Youn
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reducing the risk of bleeding. 2) A shorter duration of AF be-
fore cardioversion is a strong predictor of AF recurrence fol-
lowing cardioversion. Therefore, early cardioversion with a 
TEE-guided approach might prevent the atrial remodeling 
and enable higher rates of sinus conversion and maintenance 
of sinus rhythm. 3) A TEE-based strategy could lower total 
costs by limiting laboratory tests, reducing preprocedural 
bleeding events, and improving clinical outcomes (Table 2).
However, thromboembolic events following cardioversion 
from AF were documented among patients with absent or 
subtherapeutic anticoagulation despite a negative TEE for 
thrombus,64) possibly caused by tiny thrombi that are unde-
tected at TEE or as a result of new thrombus formation caused 
by LA/LAA stunning after cardioversion.24) Therefore, in cur-
rent practice, TEE-guided early cardioversion includes screen-
ing for an existing thrombus and therapeutic anticoagulation 
at the time of TEE, as well as post-cardioversion anticoagula-
tion prophylaxis to avoid new thrombus formation because of 
LA or LAA stunning (Fig. 11). The assessment of cardiover-
sion using transesophageal echocardiography (ACUTE) multi-
center randomized study demonstrated that embolic events 
and maintenance of sinus rhythm were similar in the two 
treatment strategies (conventional vs. TEE-guided early car-
dioversion), although the rate of hemorrhagic events was low-
er with the TEE-guided strategy.65) A new antithrombotic 
strategy of TEE-guided cardioversion with low molecular 
weight heparin has been suggested. The ACUTE II pilot 
study66) and randomized trial,67) which compared short-term 
antithbombotic therapy using low molecular weight heparin 
(LMWH) with intravenous unfractionated heparin (UFH), 
showed similar safety and efficacy with a lower length of hos-
pitalization and more sinus rhythm in the LMWH group. In 
concert with precardioversion therapeutic anticoagulation 
with UFH, LMWH, or warfarin, TEE-guided early cardiover-
sion is comparable to 4 weeks of precardioversion warfarin 
with a risk of clinical thromboembolism < 1%.65-67)
Role of Intracardiac Echocardiography  
in AF
As mentioned above, RFCA with PV isolation has become 
as an effective therapy for patients with AF.68) ICE with 2D 
and Doppler technique is widely used in the practice of inter-
ventional electrophysiology. Advances in catheter-based ultra-
sound transducers and imaging technology provide more deli-
cate images and enable direct visualization of anatomical 
structures when performing the RFCA procedures. This tech-
nique is quite safe with a negligible rate of complications and 
good patient tolerance. It allows improvement in success rate 
and decrease in complication when compared with fluoroscop-
ic approach.69) 
ICE enables the ready detection of some anatomical varia-
tions of LA such as PV and interatrial septal anatomy. Appre-
ciation of these variations is essential to guide positioning of 
the circular mapping catheter and ablation catheter. Transsep-
tal catheterization is an inevitable process of PV isolation. An-
atomical variations of interatrial septum such as aneurismal 
septum, double membrane septum, patent foramen ovale, and 
others make this process complicated. ICE helps visualize the 
interatrial septum and detect some of the related anatomical 
variations that could be trouble during transseptal puncture. 
The use of ICE helps in determining the exact position of tip 
of the transseptal sheath by looking for tenting of the inter-
atrial septum. The goal of transseptal puncture is to cross the 
septum in the posterior region of the fossa ovalis. It also en-
ables avoidance of the life-threatening complication, such as 
perforation of lateral wall of LA or aortic root.
ICE allows for the adequate placement of the circular map-
ping catheter. Exact positioning and adequate contact of the 
catheter are very important, because they make delivery of ra-
diofrequency (RF) energy effective and minimize the risk of 
complications, such as PV stenosis and thrombus formation.
ICE is useful as a monitoring tool for titration of energy 
Table 2. Advantages and disadvantages of transesophageal echo-
cardiography-guided early cardioversion
Advantages
    Shorter initial duration of AF
    Rapid resolution of symptom
    Rapid recovery of atrial mechanical function
    Increased probability of maintaining of sinus rhythm
    Shorter total duration of anticoagulation
    More cost-effective than conventional therapy
Disadvantages
    Morbidities associated with TEE
    Misdiagnosis of atrial thrombi
    Additional cost of TEE
AF: atrial fibrillation, TEE: transesophageal echocardiography
Fig. 11. Schematic flow chart of the transesophageal echocardiography-
guided early cardioversion. *Long-term oral anticoagulation if stroke risk 
factors and/or risk of AF recurrence/presence of thrombus. AF: atrial 
fibrillation, LAA: left atrial appendage, UFH: unfractionated heparin, 
LMWH: low molecular weight heparin.
+UFH or LMWH
No LAA thrombus LAA thrombus
Cardioversion 3 weeks therapeutic 
anticoagulation
4 weeks anticoagulation
*Consider long-term 
oral anticoagulation
AF of unknown or prolonged duration
TEEJournal of Cardiovascular Ultrasound 19 | June  2011
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power and/or duration. It can control lesion formation and 
prevent tissue overheating or structural perforation. Conven-
tionally, temperature, power, and impedance are monitored 
during RF energy delivery. The appearance of microbubbles 
resulting from superheating can even precede increased im-
pedance.70) Ablation needs to be terminated immediately if a 
sudden appearance of microbubbles is observed. This can pre-
vent tissue damage and scar formation which may promote 
PV stenosis, LA perforation, or pericardial effusion.71) 
ICE also allows early identification of complications related 
with procedure including damage to intracardiac structures, 
thrombus formation, PV stenosis, and pericardial effusion 
during RFCA.
ICE plays a valuable role during electrophysiologic proce-
dures. Since it provides a lot of information about the intracar-
diac structures and hemodynamic assessments, ICE is expect-
ed to be used widely in clinical practice in the near future.
Other Imaging Modalities in Management 
of AF
Other imaging modalities such as multidetector computed 
tomography (MDCT) and magnetic resonance imaging (MRI) 
provide more accurate measurement and better understanding 
of the cardiac anatomy, especially anatomical variations of PV 
and LA before RFCA of AF.72)73) MDCT and MRI have the 
additional advantage that it is operator-independent, unlike 
TTE, TTE, and ICE. As mentioned above, MDCT and MRI 
provide the best tests for evaluation of PV stenosis after RFCA 
of AF.50)
MDCT provides so high quality images of entire LA and 
each PV that these images are used with the electroanatomical 
mapping system to help guide the safe and effective RFCA of 
AF (Fig. 12).74)75) MDCT is increasingly being used to exclude 
thrombus and shows excellent negative predictive value.76) 
Another advantage of MDCT is that it enables to identify the 
extracardiac abnormalities, including pulmonary nodule, lung 
parenchymal disease, pleural abnormalities, hepatic problems, 
and others.77) 
AF promotes atrial remodeling, resulting in the loss of atrial 
myocytes and increased collagen deposit and hence fibrosis of 
the LA wall.78) Delayed-enhancement MRI using gadolinium 
contrast is a novel noninvasive method to detect and evaluate 
the degree of remodeling or fibrosis associated with AF in the 
LA tissue.79) An increased amount of enhancement within the 
LA seems to be associated with AF recurrence after RFCA.79) 
MDCT and MRI are promising tools for management of 
AF, however, radiation exposure and very high cost are the 
problem, respectively. Furthermore, it takes too long to exam-
ine and acquire images with these imaging modalities. Al-
though clinical trials of pacemakers with new designs and 
protocols are underway, the risk of performing MRI in the 
presence of a permanent pacemaker or implantable cardiovert-
er-defibrillator is still present in clinical fields. Therefore, ade-
quate combination of the various imaging modalities allows 
for the proper management of patient with AF effectively.
Conclusion
Because of the easy-accessibility, none or less-invasiveness, 
no radiation hazard, and few contraindications, both TTE and 
TEE are valuable tools that can provide cardiac anatomical 
and functional information. The advantages of echocardiogra-
phy assist in the risk stratification, diagnosis of complications, 
and management of anticoagulation in patients with AF. The 
novel technique of ICE plays an important role during percu-
taneous interventional electrophysiology. MDCT and MRI 
have complementary role to echocardiography in the manage-
ment of AF.
Ongoing advances in imaging acquisition and analysis in 
echocardiography will make the echocardiography more pop-
ular for evaluating and management of patients with AF.
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